Provided by Tiger Trade Technology Pte. Ltd.

Aquestive Therapeutics Inc.

4.78
+0.02000.42%
Post-market: 4.76-0.0200-0.42%16:22 EDT
Volume:1.69M
Turnover:8.16M
Market Cap:599.65M
PE:-7.34
High:4.98
Open:4.78
Low:4.74
Close:4.76
52wk High:7.55
52wk Low:2.93
Shares:125.45M
Float Shares:115.00M
Volume Ratio:1.02
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6512
EPS(LYR):-0.7836
ROE:148.50%
ROA:-29.20%
PB:-10.60
PE(LYR):-6.10

Loading ...

Analysts Conflicted on These Healthcare Names: Aquestive Therapeutics (AQST), Pyxis Oncology (PYXS) and Biogen (BIIB)

TIPRANKS
·
May 15

Aquestive Therapeutics (AQST) Q1 Loss Per Share Narrows Challenging Bearish Narratives

Simply Wall St.
·
May 15

Analysts Are Bullish on These Healthcare Stocks: Aquestive Therapeutics (AQST), Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
May 15

Aquestive Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 14

Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility of up to $150 Mln on May 12, 2026 - SEC Filing

THOMSON REUTERS
·
May 14

Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income

Reuters
·
May 14

BRIEF-Aquestive Therapeutics, Inc. Q1 Revenue USD 14.446 Million Vs. IBES Estimate USD 10.9 Million

Reuters
·
May 14

Aquestive Therapeutics, Inc. Outlook FY Revenue USD 46-50 Million

THOMSON REUTERS
·
May 14

Aquestive Therapeutics, Inc. Q1 Adjusted Ebitda USD -1.773 Million

THOMSON REUTERS
·
May 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

Aquestive Therapeutics Completes $150 Million Debt Refinancing With Oaktree

THOMSON REUTERS
·
May 12

Press Release: Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree

Dow Jones
·
May 12

Aquestive Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
May 12

Aquestive Therapeutics updates financial calendar for first-quarter results, investor call

Reuters
·
May 06

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Aquestive Therapeutics announces annual shareholder meeting

Reuters
·
Apr 25

Aquestive Therapeutics CLO Thomas Zalewski files initial beneficial ownership statement

Reuters
·
Apr 10